Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Ahrens

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
European Heart Journal. Acute Cardiovascular Care|November 29, 2022
Translational research in acute cardiovascular care: what does the future hold?Janine Pöss, Ingo Ahrens
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in acute coronary syndromeIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|February 7, 2023
Women in cardiovascular clinical trial leadershipJanine Pöss, Ingo Ahrens
Future Cardiology|August 9, 2012
Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndromeIngo Ahrens, Christoph Bode
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Antiplatelet therapy and anticoagulation in patients with coronary heart disease]Jan-Patrick Liedtke, Ingo Ahrens
Thrombosis and Haemostasis|September 12, 2014
Immune functions of plateletsDaniel Duerschmied, Christoph Bode, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|October 21, 2022
Intensive care unit of the future-insights in the Intensive care unit at the Samsung Medical Center in SeoulJanine Pöss, Matthias Unterhuber, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|June 6, 2023
Simulation training in acute cardiovascular careMichelle Roßberg, Ingo Ahrens, Janine Pöss
Expert Review of Cardiovascular Therapy|March 20, 2004
Use of GPIIb/IIIa inhibitors in cardiovascular medicineIngo Ahrens, Karlheinz Peter, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|July 29, 2022
Cardiogenic shock 2022: Quo vadis…? Impressions/voices from the Critical Care Clinical Trialists (3CT) WorkshopJanine Pöss, Christophe Vandenbriele, Ingo Ahrens, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
European Heart Journal. Acute Cardiovascular Care|November 29, 2022
Translational research in acute cardiovascular care: what does the future hold?Janine Pöss, Ingo Ahrens
Seminars in Hematology|May 28, 2014
Direct oral anticoagulants in acute coronary syndromeIngo Ahrens, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|February 7, 2023
Women in cardiovascular clinical trial leadershipJanine Pöss, Ingo Ahrens
Future Cardiology|August 9, 2012
Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndromeIngo Ahrens, Christoph Bode
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Antiplatelet therapy and anticoagulation in patients with coronary heart disease]Jan-Patrick Liedtke, Ingo Ahrens
Thrombosis and Haemostasis|September 12, 2014
Immune functions of plateletsDaniel Duerschmied, Christoph Bode, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|October 21, 2022
Intensive care unit of the future-insights in the Intensive care unit at the Samsung Medical Center in SeoulJanine Pöss, Matthias Unterhuber, Ingo Ahrens
European Heart Journal. Acute Cardiovascular Care|June 6, 2023
Simulation training in acute cardiovascular careMichelle Roßberg, Ingo Ahrens, Janine Pöss
Expert Review of Cardiovascular Therapy|March 20, 2004
Use of GPIIb/IIIa inhibitors in cardiovascular medicineIngo Ahrens, Karlheinz Peter, Christoph Bode
European Heart Journal. Acute Cardiovascular Care|July 29, 2022
Cardiogenic shock 2022: Quo vadis…? Impressions/voices from the Critical Care Clinical Trialists (3CT) WorkshopJanine Pöss, Christophe Vandenbriele, Ingo Ahrens, et al.
Pageof 11